PLTR, NVO & UTHR

-
The following is a makeshift summary of this Full Report.

PLTR (Originally sent on April 28, 2025)
Introduction
Palantir Technologies Inc. (PLTR) is a software company specializing in big data analytics, providing platforms for integrating, managing, and analyzing data from diverse sources. Founded in 2003, Palantir serves various sectors, including government, finance, healthcare, and manufacturing, with its Gotham, Foundry, and Apollo platforms.
TLDR
The recent buzz around Palantir Technologies (PLTR) may not be entirely organic, with some news coverage appearing sponsored. Despite potential overvaluation, the company's connection to influential figures, including a founder's association with the US President, could drive the stock price. A potential interest rate cut by the Federal Reserve could further boost the price. Currently trading at $112.78, it may be safe to buy, with potential for growth beyond $120, although momentum may slow.
Analysis
The recent buzz surrounding PLTR is noticeable, though it's difficult to assess how organic it is. The company's news coverage seems somewhat sponsored, which is a valid strategy used in the past with success. However, factors like the disappearance of long-due distortions posed by easy money and market familiarity with one-trick ponies might not be as effective as they once were.
If the Federal Reserve cuts interest rates, it could accelerate the price to fantastical regions. In my view, the company offers nothing new and unique, but markets don't behave on personal preferences. Even though it's highly overpriced, one of its founders being a close friend of the current US President could still drive the stock price.
Price Projections (Dated April 28, 2025)
It's safe to buy at the current price ($112.78), though it might appear to be losing steam. There's sufficient determination to push it beyond $120, preferably before May 5, where it might dip once more and then continue, albeit with slower acceleration.
The time series indicate an exponential nature, with projections suggesting a price of $200 by April 2026. However, there's a major dip predicted between now and then.

NVO
Introduction
Novo Nordisk (NVO) is a pharmaceutical company specializing in chronic conditions like diabetes and obesity. Its anti-obesity drug, Wegovy, is a GLP-1 receptor agonist that promotes weight loss and has shown promising results in clinical trials.

Price Projections
Based on current analysis, it's anticipated that the stock could reach $100 by mid-July and potentially stabilize at this level by late August. There's a high probability of it reaching $80, but no discernible indicators suggest it will reach $125.

UTHR
Introduction
United Therapeutics Corporation (UTHR) is a biotechnology company specializing in treatments for rare and life-threatening diseases. Its product portfolio includes Tyvaso, Remodulin, Orenitram, and Unituxin.

Price Projections
From my analysis, the outlook doesn't seem very promising. It won't register any significant increment in this current quarter (second quarter), and there's a significant chance it might decline.

Comments

Post a Comment

Popular posts from this blog

AT&T, DISNEY, INTU, MSFT, BKNG, AMZN, ALC and AES

-
Here's the PDF Introduction The selection of these equities in some portfolio could be illustrative of many things, of which I'd like to share my perspective, albeit not necessarily a definitive or universally applicable one. Selections such as these could be explained by the very real and present anticipation of high volatility in the future. This anticipation, of course, resonated with my own viewpoint, and hence the reader should be aware that this description may be biased. Nevertheless, I favour this selection set because it aligns with my objective: to be pragmatic while being cognizant of opportunities (in the classical sense, which often comes with a naturally understated visibility). AT&T, DISNEY, MSFT, AMZN, INTU, BKNG First four could be said to be true-blue American companies, having become synonymous with the American enterprise and goodwill worldwide. These offer excellent store of value, primarily gauged to withstand high volatility or a crash, making them a ...
Read more

The Age of Idiot

-
Notwithstanding the implicit provocation from the title of this blog, I would like to declare upfront that I too am, an idiot. And I've even the academic credentials too prove this, since statements such as these, usually get taken as the (understated) hallmark of the humility. Not in my case. It is an unbiased importune fact of my life that I'm a bona-fide idiot. Going by the in-vogue norm wherein a particular class, to which one belongs, bestows exclusive rights to one to exercise, (howsoever) indiscriminately. And since I do have academic credentials to prove my idiocy, which gives my right to being an idiot almost a nuclear license. Now; after having proved that I'm an idiot; in what follows, I would like to differentiate myself from the other ones. Please do keep in mind that this difference, is not due to some inherent human desire to be distinguished and gain congnizance from the fellow members, -notwithstanding the field of enterprise- albeit this is something which...
Read more